Sharofiddin Yuldashev

Dr. Sharofiddin Yuldashev

Republican Specialized Scientific-Practical Medical Center of Phthisiology and Pulmonology under Ministry of Health of the Republic of Uzbekistan
+1
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
KSKhasan Safaev
Khasan Safaev
Nargiza ParpievaNargiza Parpieva
Nargiza Parpieva
ILIrina Liverko
Irina Liverko
SYSharofiddin Yuldashev
Sharofiddin Yuldashev
KDKostyantyn Dumchev
Kostyantyn Dumchev
Anthony HarriesAnthony Harries
Anthony Harries
Uzbekistan has a high burden of drug-resistant tuberculosis (TB). Although conventional treatment for multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB) has been available since 2013, there has been no systematic documentation about its use and effectiveness. We therefore documented at national level the trends, characteristics, and outcomes of patients with drug-resistant TB enrolled for treatment from 2013–2018 and assessed risk factors for unfavorable treatment outcomes (death, failure, loss to follow-up, treatment continuation, change to XDR-TB regimen) in patients treated in Tashkent city from 2016–2017. This was a cohort study using secondary aggregate and individual patient data. Between 2013 and 2018, MDR-TB numbers were stable between 2347 and 2653 per annum, while XDR-TB numbers increased from 33 to 433 per annum. At national level, treatment success (cured and treatment completed) for MDR-TB decreased annually from 63% to 57%, while treatment success for XDR-TB increased annually from 24% to 57%. On multivariable analysis, risk factors for unfavorable outcomes, death, and loss to follow-up in drug-resistant TB patients treated in Tashkent city included XDR-TB, male sex, increasing age, previous TB treatment, alcohol abuse, and associated comorbidities (cardiovascular and liver disease, diabetes, and HIV/AIDS). Reasons for these findings and programmatic implications are discussed.

SYSharofiddin Yuldashev
Sharofiddin Yuldashev
Nargiza ParpievaNargiza Parpieva
Nargiza Parpieva
SASalikhdjan Alimov
Salikhdjan Alimov
LTLaziz Turaev
Laziz Turaev
KSKhasan Safaev
Khasan Safaev
Anthony HarriesAnthony Harries
Anthony Harries
Uzbekistan has a large burden of drug-resistant tuberculosis (TB). To deal with this public health threat, the National TB Program introduced rapid molecular diagnostic tests such as Xpert MTB/RIF (Xpert) and line probe assays (LPAs) for first-line and second-line drugs. We documented the scale-up of Xpert and LPAs from 2012–2019 and assessed whether this led to an increase in patients with laboratory-confirmed multidrug-resistant/rifampicin-resistant TB (MDR/RR-TB) and extensively drug-resistant TB (XDR-TB). This was a descriptive study using secondary program data. The numbers of GeneXpert instruments cumulatively increased from six to sixty-seven, resulting in annual assays increasing from 5574 to 107,330. A broader use of the technology resulted in a lower proportion of tests detecting Mycobacterium tuberculosis with half of the positive results showing rifampicin resistance. LPA instruments cumulatively increased from two to thirteen; the annual first-line assays for MDR-TB increased from 2582 to 6607 while second-line assays increased from 1435 in 2016 to 6815 in 2019 with about one quarter to one third of diagnosed patients showing second-line drug resistance. Patient numbers with laboratory-confirmed MDR-TB remained stable (from 1728 to 2060) but there was a large increase in patients with laboratory-confirmed XDR-TB (from 31 to 696). Programmatic implications and ways forward are discussed.

29 December 2023 in Economic Annals-ХХI
Verified
Journal Article
Closed access
UDUniversitas Teknologi Digital
Universitas Teknologi Digital
MPMeilani Purwanti
Meilani Purwanti
MAMasmin Afif
Masmin Afif
UYUniversitas Islam Negeri Sunan Kalijaga Yogyakarta
Universitas Islam Negeri Sunan Kalijaga Yogyakarta
RSRonny Siahaan
Ronny Siahaan
TUTashkent State Pedagogical University
Tashkent State Pedagogical University
Education management is one of the influencing factors in the performance of companies in various fields, including information technology. The main goals of this research are to investigate the effect of organizational learning on the financial performance of companies through the innovation process and to investigate the effect of organizational learning with innovation and innovation with financial performance. Therefore, the present study seeks to investigate the effect of education management with the mediating role of organizational learning ability and innovation on financial performance of the company. The statistical population of this descriptive research is the managers of companies active in the field of information technology in Indonesia, and the sampling method in this research is available sampling. Statistical data was prepared by distributing a questionnaire among the managers and senior experts of Indonesian IT companies. Inferential and structural equation modeling method has been used. It should be mentioned that the results of statistical analysis show a positive and significant effect of education management on organizational learning ability and business innovation of the company, a positive and significant effect of organizational learning ability on business innovation and a positive and significant effect of organizational learning ability and also business innovation on financial performance. In addition, the results show the mediating role of organizational learning ability and business innovation in the relationship between education management and financial performance. After analyzing the data using LISREL software, all three hypotheses proposed in the research were accepted.